Direct comparison of cardiac troponin I and cardiac troponin T in the detection of exercise-induced myocardial ischemia

Clinical Biochemistry

Volumn 49, Issue 6, 2016, Pages 421-432

  Sou, Seoung Mann ^a   Puelacher, Christian ^a   Twerenbold, Raphael ^a   Wagener, Max ^a   Honegger, Ursina ^a   Reichlin, Tobias ^a   Schaerli, Nicolas ^a   Pretre, Gil ^a   Abächerli, Roger ^a   Jaeger, Cedric ^a   Rubini Gimenez, Maria ^a   Wild, Damian ^a   Rentsch, Katharina M ^a   Zellweger, Michael J ^a   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Exercise induced myocardial ischemia

Indexed keywords

BIOLOGICAL MARKER; TROPONIN I; TROPONIN T;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOLOGIST; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EXERCISE; EXERCISE INDUCED MYOCARDIAL ISCHEMIA; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VISUAL ANALOG SCALE; BLOOD; COMPARATIVE STUDY; MYOCARDIAL ISCHEMIA;

EXERCISE; FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; TROPONIN I; TROPONIN T;

EID: 84952054881     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.12.005     Document Type: Article

References (40)

1. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127:e6-245. 10.1161/CIR.0b013e31828124ad.
2. Nichols M. Nick Townsend PS and MR. European Cardiovascular Disease Statistics 2012, European Heart Network, Brussels.
3. Greenland P., Gaziano J.M. Clinical practice. Selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing. N. Engl. J. Med. 2003, 349:465-473. 10.1056/NEJMcp023197.
4. Montalescot G., Sechtem U., Achenbach S., Andreotti F., Arden C., Budaj A., et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur. Heart J. 2013, 34:2949-3003. 10.1093/eurheartj/eht296.
5. Fihn S.D., Gardin J.M., Abrams J., Berra K., Blankenship J.C., Dallas A.P., et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease. J. Am. Coll. Cardiol. 2012, 60:e44-164. 10.1016/j.jacc.2012.07.013.
6. Tanglay Y., Twerenbold R., Lee G., Wagener M., Honegger U., Puelacher C., et al. Incremental value of a single high-sensitivity cardiac troponin I measurement to rule-out myocardial ischemia. Am J Med 2015, 1-9. 10.1016/j.amjmed.2015.01.009.
7. Ladapo J.A., Blecker S., Douglas P.S. Physician decision making and trends in the use of cardiac stress testing in the United States: an analysis of repeated cross-sectional data. Ann. Intern. Med. 2014, 161:482-490. 10.7326/M14-0296.
8. Rozanski A., Gransar H., Hayes S.W., Min J., Friedman J.D., Thomson L.E.J., et al. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J. Am. Coll. Cardiol. 2013, 61:1054-1065. 10.1016/j.jacc.2012.11.056.
9. Thygesen K., Mair J., Katus H., Plebani M., Venge P., Collinson P., et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur. Heart J. 2010, 31:2197-2204. 10.1093/eurheartj/ehq251.
10. Hamm C.W., Goldmann B.U., Heeschen C., Kreymann G., Berger J., Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N. Engl. J. Med. 1997, 337:1648-1653. 10.1056/NEJM199712043372302.
11. Ohman E.M., Armstrong P.W., Christenson R.H., Granger C.B. Katus H a, Hamm CW, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N. Engl. J. Med. 1996, 335:1333-1341. 10.1056/NEJM199610313351801.
12. Antman E.M., Tanasijevic M.J., Thompson B., Schactman M., McCabe C.H., Cannon C.P., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N. Engl. J. Med. 1996, 335:1342-1349. 10.1056/NEJM199610313351802.
13. Hessel M.H.M., Michielsen E.C.H.J., Atsma D.E., Schalij M.J., van der Valk E.J.M., Bax W.H., et al. Release kinetics of intact and degraded troponin I and T after irreversible cell damage. Exp. Mol. Pathol. 2008, 85:90-95. 10.1016/j.yexmp.2008.07.002.
14. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D., et al. Third universal definition of myocardial infarction. Eur. Heart J. 2012, 33:2551-2567. 10.1093/eurheartj/ehs184.
15. Reichlin T., Hochholzer W., Bassetti S., Steuer S., Stelzig C., Hartwiger S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J. Med. 2009, 361:858-867. 10.1056/NEJMoa0900428.
16. Hoeller R., Rubini Giménez M., Reichlin T., Twerenbold R., Zellweger C., Moehring B., et al. Normal presenting levels of high-sensitivity troponin and myocardial infarction. Heart 2013, 99:1567-1572. 10.1136/heartjnl-2013-303643.
17. Thygesen K., Mair J., Giannitsis E., Mueller C., Lindahl B., Blankenberg S., et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur. Heart J. 2012, 33:2252-2257. 10.1093/eurheartj/ehs154.
18. Jaffe a.S., Wu a.H.B. Troponin release-reversible or irreversible injury? Should we care?. Clin. Chem. 2012, 58:148-150. 10.1373/clinchem.2011.173070.
19. Sabatine M.S., Morrow D. a., De Lemos J a., Jarolim P, Braunwald E. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur. Heart J. 2009, 30:162-169. 10.1093/eurheartj/ehn504.
20. Kurz K., Giannitsis E., Zehelein J., Katus H.a. Highly sensitive cardiac troponin T values remain constant after brief exercise- or pharmacologic-induced reversible myocardial ischemia. Clin. Chem. 2008, 54:1234-1238. 10.1373/clinchem.2007.097865.
21. Berman D.S., Kiat H., Friedman J.D., Wang F.P., van Train K., Matzer L., et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J. Am. Coll. Cardiol. 1993, 22:1455-1464. 10.1016/0735-1097(93)90557-H.
22. Hachamovitch R., Berman D.S., Kiat H., Cohen I., Cabico J.a., Friedman J., et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996, 93:905-914. 10.1161/01.CIR.93.5.905.
23. Hachamovitch R., Berman D.S., Shaw L.J., Kiat H., Cohen I., Cabico J.a., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998, 97:535-543. 10.1161/01.CIR.97.6.535.
24. Gibbons R.J., Balady G.J., Bricker J.T., Chaitman B.R., Fletcher G.F., Froelicher V.F., et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to update the 1997 exercise testing guidelines). Circulation 2002, 106:1883-1892. 10.1161/01.CIR.0000034670.06526.15.
25. Fletcher G.F., Ades P.a., Kligfield P., Arena R., Balady G.J., Bittner V.a., et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation 2013, 128:873-934. 10.1161/CIR.0b013e31829b5b44.
26. Hendel R.C., Berman D.S., Di Carli M.F., Heidenreich P.a., Henkin R.E., Pellikka P.a., et al. Appropriate use criteria for cardiac radionuclide imaging. J. Am. Coll. Cardiol. 2009, 53:2201-2229. (ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009). 10.1016/j.jacc.2009.02.013.
27. Røysland R., Kravdal G., Høiseth A.D., Nygård S., Badr P., Hagve T., et al. Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study. Clin. Sci. 2012, 122:599-606. 10.1042/CS20110557.
28. Røsjø H., Kravdal G., Høiseth A.D., Jørgensen M., Badr P., Røysland R., et al. Troponin I measured by a high-sensitivity assay in patients with suspected reversible myocardial ischemia: data from the akershus cardiac examination (ACE) 1 study. Clin. Chem. 2012, 58:1565-1573. 10.1373/clinchem.2012.190868.
29. Diamond G.a., Forrester J.S. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N. Engl. J. Med. 1979, 300:1350-1358. 10.1056/NEJM197906143002402.
30. Weiner D. a, Ryan TJ, McCabe CH, Kennedy JW, Schloss M, Tristani F, et al. Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS). N. Engl. J. Med. 1979, 301:230-235. 10.1056/NEJM197908023010502.
31. Mansour M., Clark L., Kavsak P.A. Effect of freeze-thaw and refrigeration conditions on high-sensitivity troponin T concentrations. Ann. Clin. Biochem. 2011, 49:101-102. 10.1258/acb.2011.011204.
32. Basit M., Bakshi N., Hashem M., Allebban Z., Lawson N., Rosman H.S., et al. The effect of freezing and long-term storage on the stability of cardiac troponin T. Am. J. Clin. Pathol. 2007, 128:164-167. 10.1309/LR7FC0LUGLHT8X6J.
33. Rezvanpour A., Shortt C., Clark L., Worster A., Kavsak P.A. Analytical factors to consider when assessing a high-sensitivity cardiac troponin I assay compared to a contemporary assay in clinical studies. Clin. Chim. Acta 2014, 429:6-7. 10.1016/j.cca.2013.11.012.
34. Giannitsis E., Becker M., Kurz K., Hess G., Zdunek D., Katus H.A. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin. Chem. 2010, 56:642-650. 10.1373/clinchem.2009.134460.
35. Koerbin G., Tate J., Potter J.M., Cavanaugh J., Glasgow N., Hickman P.E. Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population. Clin. Chem. Lab. Med. 2012, 50:871-878. 10.1515/cclm-2011-0540.
36. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845. 10.2307/2531595.
37. Ndrepepa G., Braun S., Mehilli J., Birkmeier K.A. Byrne R a., Ott I, et al. Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. Am. Heart J. 2011, 161:68-75. 10.1016/j.ahj.2010.09.018.
38. Omland T., de Lemos J.a., Sabatine M.S., Christophi C.A., Rice M.M., Jablonski K.a., et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N. Engl. J. Med. 2009, 361:2538-2547. 10.1056/NEJMoa0805299.
39. Hickman P.E., Potter J.M., Aroney C., Koerbin G., Southcott E., Wu A.H.B., et al. Cardiac troponin may be released by ischemia alone, without necrosis. Clin. Chim. Acta 2010, 411:318-323. 10.1016/j.cca.2009.12.009.
40. Turer A.T., Addo T.a., Martin J.L., Sabatine M.S., Lewis G.D., Gerszten R.E., et al. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study. J. Am. Coll. Cardiol. 2011, 57:2398-2405. 10.1016/j.jacc.2010.11.066.